Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Proper education can prevent traction alopecia in women of color.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Early treatment helps stop hair loss in women of color.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

PRP and cell therapies may help with hair loss, but more research is needed.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Lupus patients' body image issues significantly affect their mental health and need more support.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Effective symptom management in IBD improves quality of life and prevents complications.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

The free clinic successfully provided specialized skin care to uninsured patients.